Garuda - Garba Rujukan Digital

p-Index From 2021 - 2026

2.383

P-Index

This Author published in this journals

All Journal International Journal of Public Health Science (IJPHS) Medical Journal of Indonesia Health Notions Qanun Medika - Medical Journal Faculty of Medicine Muhammadiyah Surabaya Biomolecular and Health Science Journal JUXTA: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga Medica Arteriana (Med-Art) Majalah Biomorfologi (Biomorphology Journal) Cardiovascular and Cardiometabolic Journal (CCJ) CURRENT INTERNAL MEDICINE RESEARCH AND PRACTICE SURABAYA JOURNAL Indian Journal of Forensic Medicine & Toxicology The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy Journal of Global Pharma Technology Jurnal Penyakit Dalam Indonesia Indonesian Journal of Endocrinology Metabolism and Diabetes (InaJEMD) Folia Medica Indonesiana

Soelistijo, Soebagijo Adi

Departemen Ilmu Penyakit Dalam RSUD Dr. Soetomo – Fakultas Kedokteran Universitas Airlangga, Surabaya

Author-ID : 1252255

Biochemistry, Genetics & Molecular Biology Dentistry Health Professions Immunology & microbiology Medicine & Pharmacology Neuroscience Nursing Public Health

Published : 22 Documents Claim Missing Document

Claim Missing Document

Articles

1 2 3

The Use of Canagliflozin in Diabetes Mellitus Type 2 on Renal Outcome: A Systematic Review Haikal, Vikri; Soelistijo, Soebagijo Adi; Puspa; Prajitno, Jongky Hendro
Current Internal Medicine Research and Practice Surabaya Journal Vol. 5 No. 1 (2024): CURRENT INTERNAL MEDICINE RESEARCH AND PRACTICE SURABAYA JOURNAL
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/cimrj.v5i1.50710

Introduction: One of the leading causes of death in patients with diabetes mellitus is Diabetic Kidney Disease (DKD). Canagliflozin is one of the therapeutic options that can be used to mitigate the progression of DKD. However, the limited existing studies have left the data regarding the effects of canagliflozin on the progression of DKD still unclear. Therefore, a comprehensive study on the efficacy and safety of using canagliflozin in patients with DKD is warranted.Methods: We performed a systematic search in the PubMed, Cochrane Library, ResearchGate, and Springer for randomized, placebo-controlled trials of the treatment of type 2 diabetes mellitus (T2DM) with canagliflozin that were published. A total of 25 journals were identified, and after excluding irrelevant studies, eighteen studies were ultimately included in this systematic review with total participants of 20,047.Results: Canagliflozin reduces the rate of estimated glomerular filtration rate (eGFR) decline in patients with diabetes mellitus. The reduction of urinary albumin-to-creatinine ratio (UACR) level was greater in canagliflozin group than in the control group, and the progression of albuminuria was slower in the canagliflozin group than in the control group.Conclusion: The use of Canagliflozin is considered to be one of the effective therapeutic options for kidney protection in patients with diabetes mellitus who are at risk of chronic kidney disease (CKD).

Association of Metabolic Syndrome with Albuminuria in Diabetes Mellitus Type 2 Thamrin, Husin; Sutjahjo, Ari; Pranoto, Agung; Soelistijo, Soebagijo Adi
Biomolecular and Health Science Journal Vol. 2 No. 2 (2019): Biomolecular and Health Science Journal
Publisher : Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia

Background : Metabolic syndrome is a risk factor for cardiovascular disease as well as the occurrence of chronic kidney disease. According to the IDF, the metabolic syndrome is diagnosed when central obesity obtained with 2 or more metabolic abnormalities that include impaired glucose metabolism, increased blood pressure, hypertriglyceridemia, and low HDL-C. Several previous studies reported an significant association found between the metabolic syndrome with albuminuria. In Indonesia, the association of metabolic syndrome with albuminuria in type 2 diabetes have not been.reported.Objectives : To investigate the association of metabolic syndrome with albuminuria in type 2 diabetes patients.Methods : This is an analytic observational study, cross-sectional design in type 2 diabetes mellitus patients and we studied 131 subjects. Criteria metabolic syndrome according to IDF consensus and albuminuria assessed using the ACR method and the classification of albuminuria was based on consensus of Perkeni 2006. As for Statistical analysis using spearman correlation and Mann-whitney test. Significance level used was 0.05.Results : Of the 131 type 2 diabetes patients with metabolic syndrome were found normoalbuminuria proportion 65.4%, microalbuminuria 27.1% and macroalbuminuria 7.5%. Obtained a significant association between systolic blood pressure with albuminuria, p = 0.000, r = 0.325. Fasting blood sugar with albuminuria, p = 0.01, r = 0.223. But not found significant association between diastolic blood pressure with albuminuria, p = 0.153, r = 0.125, waist circumference with albuminuria, p = 0.311, r = 0.089, low HDL with albuminuria p = 0.771, r = -0.025. Hypertriglyceridemia with albuminuria, p = 0.727 and r=0,031 Conclusion : The results of this study indicate a strong association between the components of metabolic syndrome, systolic blood pressure with albuminuria, and fasting blood sugar with albuminuria. Whereas diastolic blood pressure, waist circumference, low HDL, and hypertriglyceridemia were not found significant associations.

Association between Serum Magnesium Level with Acute Coronary Syndrome (ACS) in Diabetes Mellitus (DM) Patients Wulansari, Ratih; Soelistijo, Soebagijo Adi; Lefi, Achmad
Biomolecular and Health Science Journal Vol. 2 No. 2 (2019): Biomolecular and Health Science Journal
Publisher : Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia

Introduction: Until now, cardiovascular complications are still the highest cause of death and disability in DM patients. Hypomagnesemia in DM accelerate atherosclerosis and can cause instability and plaque rupture which can lead to acute coronary syndrome.Methods: Design of this study was observational analytic using a "case control" study involved 76 samples of DM patients, consisting of 38 samples with SKA (+) and 38 samples with SKA (-). Subjects of this study were all DM patients in the period July-December 2018 in the Emergency Room (ER) and Outpatient Installation of Endocrine at the RSUD Dr. Soetomo Surabaya, which fulfills the criteria for inclusion and exclusion. Demographic data and clinical characteristics are presented descriptively. If data is normally distributed then an unpaired t test is carried out and if the data is not normally, distributed with Mann Whitney test is performed. The statistical test was stated to be significant if p <0.05. The association between hypomagnesemia and the incidence of ACS a multivariate logistic regression test was performed, the risk number was in the form of odds ratios (OR). Results: This study involved 76 subjects with diabetes mellitus with SKA and non SKA 38 subjects. The mean serum magnesium level in the ACS group was lower than non ACS (1.9 mg / dL vs. 2.1 mg / dL), hypomagnesemia cut-off of <2.08 mg / dL. In this study hypomagnesemia as a risk factor for the incidence of ACS in DM patients with OR 2.8 (CI 1.1-7.6; p = 0.039).Conclusion: Magnesium levels in the ACS group were lower than the non ACS group. Hypomagnesemia Increase The Incidence of Acute Coronary Syndrome in Diabetes Mellitus Patients.

Triglyceride to high-density lipoprotein cholesterol ratio as a marker of non-alcoholic fatty liver disease in type 2 diabetes Dwitama Adiwinoto, Robert; Pranoto, Agung; Sugihartono, Titong; Adi Soelistijo, Soebagijo; Pratama Adiwinoto, Ronald
International Journal of Public Health Science (IJPHS) Vol 13, No 3: September 2024
Publisher : Intelektual Pustaka Media Utama

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.11591/ijphs.v13i3.24035

Type 2 diabetes mellitus (T2DM) and non-alcoholic liver disease (NAFLD) shared a common feature, insulin resistance (IR), which is marked by a change in the lipoprotein fraction, namely increased triglycerides (TG) and decreased high-density lipoprotein cholesterol (HDL-C) levels. Blood lipids are routinely examined in T2DM patients; thus, our study aimed to investigate the performance of TG/HDL-C ratio values to identify hepatic steatosis, the earliest manifestation of nonalcoholic fatty liver disease (NAFLD), in T2DM patients. One hundred adult T2DM patients over 30 years old were recruited from the diabetes outpatient clinic at the Dr. Soetomo General Academic Hospital from August to October 2023. Data regarding sociodemographics, medication, glycosylated hemoglobin (HbA1c), lipid profiles, and FibroScan with controlled attenuation parameter (CAP) were collected from all participants. The group with hepatic steatosis (CAP≥237 dB/m) had a higher body mass index (BMI), higher TG levels, and TG/HDL-C ratio values. The TG/HDL-C ratio was significantly correlated with CAP values. Hepatic steatosis can be identified using the TG/HDL-C ratio with a cut-off value of 2.83 (sensitivity:72.4%; specificity:71.4%). An elevated TG/HDL-C ratio is associated with a higher risk (OR:6.562; p<0.05) of having hepatic steatosis. The TG/HDL-C ratio is a potential marker to predict NAFLD in T2DM patients.

Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Current Pathogenic Paradigm and Therapeutic Aspect Maimunah, Ummi; Soelistijo, Soebagijo Adi; Hadisuwarno, Wiharjo; Miftahussurur, Muhammad
The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy Vol 24, No 2 (2023): VOLUME 24, NUMBER 2, August, 2023
Publisher : The Indonesian Society for Digestive Endoscopy

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24871/2422023154-162

Changes in the gut microbiota are essential factors that cause non-alcoholic fatty liver disease (NAFLD), obesity, and diabetes. Small intestine bacteria overgrowth is discovered in NAFLD patients. Disruptions in the gut-liver axis include environmental factors that induce microbiota dysbiosis and/or increased intestinal permeability that causes liver inflammation. The most recommended therapy for NAFLD patients is still limited to lifestyle changes. This review will describe the role of the gut microbiota in the pathogenesis and therapeutic intervention of NAFLD. Recent evidence reveals that the gut microbiota is one of the main factors in the pathogenesis and progression of NAFLD through several mechanisms, particularly dysbiosis. This significant role makes the gut microbiota a non-invasive biomarker for NAFLD examination and a more effective therapeutic target.

Risk Factor Profile of Amputation in Diabetic Foot Patients in Dr. Soetomo General Academic Hospital, Surabaya, from 2019 to 2020 Adhibagio, Aria Damarjiwo; Soelistijo, Soebagijo Adi; Hakim, Arief Rakhman; Prasmono, Agung
JUXTA: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga Vol. 15 No. 1 (2024): Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/juxta.V15I12024.8-16

Highlights: Certain variables are known to be risk factors associated with the outcome of lower extremity amputation among diabetic foot patients. The patient population was observed to be slightly female-biased, with a high prevalence of older age, abnormally high blood sugar and HbA1c, and a history of nephropathy, dyslipidemia, and hypertension. Prior history of vascular diseases, prior amputation history, and heavy smoking were observed but not as prevalent. Abstract Introduction: This study aimed to find the general distribution of certain variables as risk factors for lower extremity amputation among diabetic foot patients at the Inpatient Ward of the Department of Internal Medicine, Dr. Soetomo General Academic Hospital, Surabaya, from 2019 to 2020. Methods: This was a descriptive-retrospective study using data from medical records. The International Business Machines Corporation (IBM) Statistical Package for the Social Sciences (SPSS) version 26 was used to calculate the distribution. Results: The mean ± SD of age was 55.38 ± 7.503 years old and was slightly female-biased. The median (min-max) blood sugar level was 212.00 (85–446) mg/dL. Fifteen out of 16 patients had an HbA1c beyond 7.0%. The body mass index (BMI) of most patients was between normal and overweight, with a mean ± SD of 24.018 ± 4.1827. Fifteen percent of patients were smokers. Strokes were present in 3.9% of patients, cardiovascular diseases were present in 13.73% of patients, prior lower extremity amputation (LEA) history was present in 15.7% of patients, hypertension was present in 49% of patients, and dyslipidemia was present in 13 of 15 patients. The mean estimated glomerular filtration rate (eGFR) was 70.15 ± 34.498 mL/min/1.732. Conclusion: Older age, high blood sugar, high HbA1c levels, nephropathy, dyslipidemia, and hypertension had a high prevalence. Smoking, cardiovascular diseases, strokes, and prior amputation had a low prevalence. Gram-negative bacterial infection was observed in almost all reported patients. ABI results were either mostly not assessable or abnormally high. Most of the patients' Wagner gradings were in the worst category.

Trend Analysis of Clinical Characteristics of COVID-19 with Diabetes Based on Disease Severity Batari Retno Minanti; Soebagijo Adi Soelistijo; Agung Pranoto
‎ InaJEMD - Indonesian Journal of Endocrinology Metabolic and Diabetes Vol. 1 No. 1 (2024): InaJEMD Vol. 1, No. 1
Publisher : PP PERKENI

Show Abstract | Download Original | Original Source | Check in Google Scholar

Diabetes Mellitus (DM) increases the risk of COVID-19's severity and mortality than those without DM. The aim of this study was to determine the characteristics and trends by disease severity of DM patients with COVID-19. Across-sectional study examining retrospective medical records was conducted in patients with diabetes mellitus who were confirmed to have COVID-19 by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). All adult patients (age > 18 years) with DM and COVID-19 registered and treated at the Surabaya Hajj General Hospital from May 2021 to the end of December 2021 were included in this study. Trends in each subject's characteristics are displayed in a graph with a trendline based on the severity of COVID-19. The highest proportionof disease severity of DM patients with COVID-19 is mild and moderate cases (72.2%), with 27.8% severe and critical cases. The average aged of the subjects was 56.38 ± 9.60 years. The age group with the highest proportion was 50-59 (42.6%). There are slightly more female than male patients (50.4% vs. 49.6%). The tendency is that the disease's severity increases with BMI, increasing HbA1C level, low sodium level, high chloride level, and high CRP and D-dimer levels. The pattern of clinical and laboratory features of DM patients based on the severity of COVID-19 infection shows the tendency for the disease severity worsens with increasing BMI, HbA1C level, low sodium level, high chloride level, and high CRP and D- dimer levels.

Pregnancy Following Recent Radioactive Iodine Ablation in Thyroid Cancer Patient A Case Report Robert Dwitama Adiwinoto; Soebagijo Adi Soelistijo; Hermina Novida; Agung Pranoto
‎ InaJEMD - Indonesian Journal of Endocrinology Metabolic and Diabetes Vol. 1 No. 1 (2024): InaJEMD Vol. 1, No. 1
Publisher : PP PERKENI

Show Abstract | Download Original | Original Source | Check in Google Scholar

Well-differentiated thyroid carcinoma (DTC) is common among females of reproductive age. Pregnancy is associated with hormonal (TSH and HCG) and metabolic changes that might affect the thyroid gland. Informationregarding the outcome of babies born to mothers who have recently undergone radioactive Iodine-131 ablation (RAI) is scarce. A 24-year-old pregnant woman with a history of thyroid cancer was consulted by the obstetrics and gynecology for further evaluation. She complained of a lump under the left jaw, and a thyroid nodule was found from further examination. Postoperative pathology of the right thyroid tissue revealed follicular and solid variant papillary thyroid carcinoma. Postoperative Thyroglobulin (Tg) level before ablation was 16.14 ng/mL. Ablation with Iodine-131 of 100 mCi was performed. Whole-body scintigraphy (WBS) indicated remaining functional thyroid tissue in the right thyroid field and thyroid tissue metastases in the left supraclavicular area. The patient waspregnant 3 months after the radioablation. Fetomaternal examination results 6 months pregnancy revealed fetal biometry according to gestational age (31 – 32 weeks) with an estimated fetal weight of 1787 grams and fetal doppler was normal. The patient is treated with levothyroxine 125 μ g once daily, folic acid 400 μ g twice daily, calcium lactate twice daily, and aspirin 80 mg once daily. The TSH level was 0.01 (0.55 – 4.78) μ IU/mL and the fT4 was 1.14 (0.7 – 1.48) ng/dL. The latest thyroid ultrasound indicated no discrete mass in the thyroid fossa and non-specific lymphadenopathies. The baby was born normally, weighed 2680 grams, with normal thyroid function tests (neonatal TSH 1.02 μ IU/mL, fT4 2.6 ng/dL).

Challenges in the Diagnosis and Management of Adrenal Insufficiency Febri Kurniawati; Sony Wibisono Mudjanarko; Soebagijo Adi Soelistijo; Agung Pranoto
‎ InaJEMD - Indonesian Journal of Endocrinology Metabolic and Diabetes Vol. 1 No. 1 (2024): InaJEMD Vol. 1, No. 1
Publisher : PP PERKENI

Show Abstract | Download Original | Original Source | Check in Google Scholar

Adrenal insufficiency (AI) is a rare endocrine condition. Primary adrenocortical insufficiency, or Addison diseases reduces the production of crucial hormones, including glucocorticoids, mineralocorticoids, and adrenal androgens. Due to the lack of proper cortisol response in adrenal crisis, it can be life-threatening during times of stress, emphasizing the need for a timely diagnosis. Despite this, diagnosing and managing AI still presents significant challenges. We report the case of a middle-aged woman who presented with complaints of weight loss, abdominalpain, lethargy, hyperpigmentation of the skin and mucosa, and a history of repeated hospitalizations for nausea, vomiting, dehydration, and hypovolemia. During the patient's previous hospitalization, Addison's crisis was suspected, and methylprednisolone therapy was administered, rendering the cortisol and ACTH assays inaccurate. The patient's condition subsequently improved. The subsequent monitoring revealed low cortisol levels, but an ACTH stimulation test was unavailable. The presence of pulmonary tuberculosis was indicated by a positive chest X-ray and IFN-Gamma Release Assay (IGRA) test. With a history of repeated hospitalizations, suspected Addison's crisis, hypoglycemia, mineralocorticoid involvement (hypotension, hyponatremia), and the presence of hyperpigmentation, a clinical diagnosis of primary adrenal insufficiency was made with limited conditions and testing tools. The patient was given anti-tuberculosis treatment and the lowest dose of hydrocortisone required to control the disease without causing side effects.

Association between HbA1c and Non-HDL-Cholesterol in Type 2 Diabetes Mellitus at a Tertiary Hospital in Indonesia Putri, Karina Widya; Soelistijo, Soebagijo Adi; Prabowo, Gwenny Ichsan
Cardiovascular and Cardiometabolic Journal (CCJ) Vol. 6 No. 2 (2025): Cardiovascular and Cardiometabolic Journal
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/ccj.v6i2.2025.73-82

Abstract: Diabetic dyslipidaemia is considered a modifiable risk factor for cardiovascular disease (CVDs). Non-high-density lipoprotein-cholesterol (non-HDL-C) is a better predictive measure of CVD compared to glycosylated haemoglobin (HbA1c) in type 2 diabetic. This study aims to explore the intricate link between these variables, which contribute significantly to the health risks of T2DM, particularly in a clinical environment like Dr. Soetomo's Endocrinology Polyclinic. Material and Methods: This study used a cross-sectional method with observational analytics design to determine the correlation between HbA1c and non-HDL cholesterol in Type 2 Diabetes Mellitus. Data was collected at Dr. Soetomo Surabaya's Endocrinology Polyclinic from April 2022 to May 2023, focusing on medical records of Type 2 Diabetes Mellitus (T2DM) patients with dyslipidaemia. The study involved T2DM outpatients meeting specific criteria and excluded those with incomplete records or stage 5 Chronic Kidney Disease (CKD) diagnosis at the clinic. The data processing utilized the SPSS statistical program to examine the correlation between independent and dependent variables, employing Pearson or Spearman Correlation based on the data's distribution. Results: The study included mostly women (66.67%) averaging 52.11 years old (SD 4.61). Simvastatin was the most prescribed statin (60.92%). Mean values for HbA1c, total cholesterol, HDL, LDL, and non-HDL cholesterol were 8.155%, 217.29 mg/dL, 46.61 mg/dL, 141.37 mg/dL, and 170.68 mg/dL. Most had poor glycemic control and cholesterol ≥ 130 mg/dL. The Spearman test showed a strong positive correlation between HbA1c and non-HDL cholesterol (r=0.534; p<0.001) and a moderate positive correlation with LDL cholesterol (r=0.473; p<0.001). Conclusion: There is a strong correlation between HbA1c and non-HDL cholesterol in Type 2 Diabetes Mellitus. -- Highlights: 1. A significant positive correlation was observed between HbA1c and non-HDL cholesterol levels in patients with Type 2 Diabetes Mellitus, indicating a linked progression of glycemic and atherogenic profiles. 2. The findings support non-HDL cholesterol as a reliable and cost-efficient parameter for assessing cardiovascular risk, complementing or surpassing LDL cholesterol in clinical evaluation.

Co-Authors Adhibagio, Aria Damarjiwo Agung Dwi Wahyu Widodo Agung Pranoto AGUNG PRANOTO Alhakiim, Muhammad Valeri Amatlulloh, Hasna Shahida Ardiany, Deasy Ari Sutjahjo, Ari Ariana, Audy Meutia Artaria Tjempakasari, Artaria Audy Meutia Ariana Bambang Purwanto Batari Retno Minanti Chabib Fachry Albab Chandra Adi Irawan Primasatya Dewi Ratna Sari Dwitama Adiwinoto, Robert Fajar Setiyawan Febri Kurniawati Febrianto, Dicky Hadisuwarno, Wiharjo Hafizha Firdaus Al-Fuady Haikal, Vikri Hakim, Arief Rakhman Hasna Shahida Amatlulloh Hendra Gunawan Hermina Novida, Hermina Jayawarsa, A.A. Ketut Jihan Jauza Fairuz Jongky Hendro Prajitno Jusak Nugraha Lefi, Achmad Lenny Octavia Lusida, Michael Austin Pradipta Lutfi Dewanda Nugroho Lutfi, Delfitri Muhammad Miftahussurur Muhammad Valeri Alhakiim Nadhya Allia Nurainy Trias Setyoputri Poernomo Boedi Setiawan Prabowo, Gwenny Ichsan Pradhevi, Lukita Prasmono, Agung Prastyani, Reni Primasatya, Chandra Adi Irawan Puspa Putri, Karina Widya Rejeki, Purwo Sri Robert Dwitama Adiwinoto Ronald Pratama Adiwinoto Saefudin, Rendra Prasetya Sasono, Wimbo Sony Wibisono Thamrin, Husin Titong Sugihartono Ummi Maimunah Vincent, Agustinus Wulansari, Ratih

Title

Found 22 Documents
Search

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Title Search

Found 22 Documents Search

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Title

Found 22 Documents
Search